Predictors of successful whole-body hyperthermia in cancer patients: target temperature achievement and safety analysis
Aim: This study aimed to investigate the effectiveness and safety of whole-body hyperthermia (WBH) in cancer patients, identifying predictive factors for successful treatment (reaching target temperature ≥ 38.5 °C) and assessing adverse effects. Methods: We conducted a retrospective analysis of 397...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
21 August 2025
|
| In: |
Cancers
Year: 2025, Jahrgang: 17, Heft: 16, Pages: 1-13 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers17162716 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers17162716 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/17/16/2716 |
| Verfasserangaben: | Anna Lena Hohneck, Vivien Schmitz-Solheid, Deniz Gencer, Maik Schroeder, Hartmut Riess, Annette Gerhards, Iris Burkholder, Stefan Heckel-Reusser, Julia Gottfried and Ralf-Dieter Hofheinz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1940752906 | ||
| 003 | DE-627 | ||
| 005 | 20251112134437.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251110s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers17162716 |2 doi | |
| 035 | |a (DE-627)1940752906 | ||
| 035 | |a (DE-599)KXP1940752906 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hohneck, Anna |d 1990- |e VerfasserIn |0 (DE-588)1194587674 |0 (DE-627)1676810412 |4 aut | |
| 245 | 1 | 0 | |a Predictors of successful whole-body hyperthermia in cancer patients |b target temperature achievement and safety analysis |c Anna Lena Hohneck, Vivien Schmitz-Solheid, Deniz Gencer, Maik Schroeder, Hartmut Riess, Annette Gerhards, Iris Burkholder, Stefan Heckel-Reusser, Julia Gottfried and Ralf-Dieter Hofheinz |
| 246 | 1 | |i Titel des übergeordneten Special issue |a Integrated management of cancer (2nd edition) | |
| 264 | 1 | |c 21 August 2025 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.11.2025 | ||
| 520 | |a Aim: This study aimed to investigate the effectiveness and safety of whole-body hyperthermia (WBH) in cancer patients, identifying predictive factors for successful treatment (reaching target temperature ≥ 38.5 °C) and assessing adverse effects. Methods: We conducted a retrospective analysis of 397 cancer patients receiving a total of 855 WBH treatment sessions at a single institution between January 2018 and December 2018. Results: A total of 855 WBH treatments were performed on 397 patients (76.6% female; median age 58 years). The most common cancer types included breast cancer (52.4%), followed by prostate cancer (13.1%) and gynecological cancers (10.6%), with 54.7% of patients having metastatic disease. Target temperature was reached in 90.1% (770 of 855) of sessions, with a median treatment time of 202 min and maximum temperature of 40.4 °C. Common side effects included headache (54.9%), skin reactions (11.7%), and cardiac effects (9.4%), with no serious adverse events. Serum creatinine (p = 0.01, OR 0.30, 95% CI: 0.11-0.78) and secale cornutum/galena co-medication during WBH (p < 0.001, OR 0.26 [0.12, 0.54]) emerged as independent predictors of achieving target temperature in multivariate analysis. Both elevated creatinine levels and the use of secale cornutum/galena were associated with an approximately 70% lower probability of achieving the target temperature. Conclusions: WBH demonstrates safety in cancer patients with high success rates in reaching target temperatures. Both elevated creatinine levels and the use of secale cornutum/galena were associated with a lower chance of reaching the target temperature and thus impacting and predicting WBH success. | ||
| 650 | 4 | |a integrative oncology | |
| 650 | 4 | |a safety | |
| 650 | 4 | |a serum creatinine | |
| 650 | 4 | |a whole-body hyperthermia | |
| 700 | 1 | |a Schmitz-Solheid, Vivien |d 1993- |e VerfasserIn |0 (DE-588)138120693X |0 (DE-627)1940753627 |4 aut | |
| 700 | 1 | |a Gencer, Deniz |d 1980- |e VerfasserIn |0 (DE-588)140107940 |0 (DE-627)616027850 |0 (DE-576)314627332 |4 aut | |
| 700 | 1 | |a Schroeder, Maik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rieß, Hartmut |d 1962- |e VerfasserIn |0 (DE-588)1145733352 |0 (DE-627)100688985X |0 (DE-576)168771721 |4 aut | |
| 700 | 1 | |a Gerhards, Annette |d 1969- |e VerfasserIn |0 (DE-588)12136206X |0 (DE-627)705410110 |0 (DE-576)181479397 |4 aut | |
| 700 | 1 | |a Burkholder, Iris |e VerfasserIn |0 (DE-588)1176548557 |0 (DE-627)104754671X |0 (DE-576)516671278 |4 aut | |
| 700 | 1 | |a Heckel-Reusser, Stefan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gottfried, Julia |d 1979- |e VerfasserIn |0 (DE-588)101689662X |0 (DE-627)671850490 |0 (DE-576)352810106 |4 aut | |
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |e VerfasserIn |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 17(2025), 16, Artikel-ID 2716, Seite 1-13 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Predictors of successful whole-body hyperthermia in cancer patients target temperature achievement and safety analysis |
| 773 | 1 | 8 | |g volume:17 |g year:2025 |g number:16 |g elocationid:2716 |g pages:1-13 |g extent:13 |a Predictors of successful whole-body hyperthermia in cancer patients target temperature achievement and safety analysis |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers17162716 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/17/16/2716 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251110 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61200 |e 60000PH121917517 |e 61200PH121917517 |k 0/60000/ |k 1/60000/61200/ |p 10 |y j | ||
| 998 | |g 1176548557 |a Burkholder, Iris |m 1176548557:Burkholder, Iris |d 140000 |e 140000PB1176548557 |k 0/140000/ |p 7 | ||
| 998 | |g 140107940 |a Gencer, Deniz |m 140107940:Gencer, Deniz |d 60000 |e 60000PG140107940 |k 0/60000/ |p 3 | ||
| 998 | |g 138120693X |a Schmitz-Solheid, Vivien |m 138120693X:Schmitz-Solheid, Vivien |d 60000 |e 60000PS138120693X |k 0/60000/ |p 2 | ||
| 998 | |g 1194587674 |a Hohneck, Anna |m 1194587674:Hohneck, Anna |d 60000 |d 61000 |d 60000 |d 910000 |d 910100 |e 60000PH1194587674 |e 61000PH1194587674 |e 60000PH1194587674 |e 910000PH1194587674 |e 910100PH1194587674 |k 0/60000/ |k 1/60000/61000/ |k 0/60000/ |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1940752906 |e 4801901344 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"part":{"text":"17(2025), 16, Artikel-ID 2716, Seite 1-13","volume":"17","extent":"13","year":"2025","pages":"1-13","issue":"16"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Cancers","title_sort":"Cancers"}],"disp":"Predictors of successful whole-body hyperthermia in cancer patients target temperature achievement and safety analysisCancers","name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"origin":[{"publisher":"MDPI","dateIssuedDisp":"2009-","publisherPlace":"Basel","dateIssuedKey":"2009"}],"recId":"614095670","id":{"zdb":["2527080-1"],"eki":["614095670"],"issn":["2072-6694"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 27.05.2020"],"pubHistory":["1.2009 -"],"language":["eng"]}],"title":[{"title":"Predictors of successful whole-body hyperthermia in cancer patients","title_sort":"Predictors of successful whole-body hyperthermia in cancer patients","subtitle":"target temperature achievement and safety analysis"}],"physDesc":[{"extent":"13 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.3390/cancers17162716"],"eki":["1940752906"]},"recId":"1940752906","name":{"displayForm":["Anna Lena Hohneck, Vivien Schmitz-Solheid, Deniz Gencer, Maik Schroeder, Hartmut Riess, Annette Gerhards, Iris Burkholder, Stefan Heckel-Reusser, Julia Gottfried and Ralf-Dieter Hofheinz"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"21 August 2025"}],"language":["eng"],"titleAlt":[{"title":"Integrated management of cancer (2nd edition)"}],"note":["Gesehen am 10.11.2025"],"person":[{"role":"aut","family":"Hohneck","display":"Hohneck, Anna","given":"Anna"},{"display":"Schmitz-Solheid, Vivien","role":"aut","family":"Schmitz-Solheid","given":"Vivien"},{"given":"Deniz","display":"Gencer, Deniz","role":"aut","family":"Gencer"},{"display":"Schroeder, Maik","role":"aut","family":"Schroeder","given":"Maik"},{"display":"Rieß, Hartmut","role":"aut","family":"Rieß","given":"Hartmut"},{"display":"Gerhards, Annette","role":"aut","family":"Gerhards","given":"Annette"},{"family":"Burkholder","role":"aut","display":"Burkholder, Iris","given":"Iris"},{"given":"Stefan","role":"aut","family":"Heckel-Reusser","display":"Heckel-Reusser, Stefan"},{"given":"Julia","family":"Gottfried","role":"aut","display":"Gottfried, Julia"},{"given":"Ralf-Dieter","family":"Hofheinz","role":"aut","display":"Hofheinz, Ralf-Dieter"}]} | ||
| SRT | |a HOHNECKANNPREDICTORS2120 | ||